Lixisenatide and exenatide used in ELIXA and EXSCEL trials are short-acting GLP-1RAs that are structurally similar to exendin-4, a peptide found in the saliva of the Gila monster Heloderma suspectum
Studies suggest that people who lose weight quickly, particularly with the aid of medications like GLP-1 receptor agonists, may have a higher likelihood of developing gallstones, which can cause severe abdominal pain and may require surgical intervention
This highlights microbiological safety issues associated with commercial Spirulina products (Rhoades et al
Brenda makes the case for a "vicious cycle" with common roots in genetics, lifestyle and childhood adversity
Personalized Doses: Your healthcare provider will tailor the Semaglutide doses to your specific health needs, adjusting the treatment over time to optimize results
Yet for many individuals dealing with obesity, diet and exercise alone produce limited results